These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 32560266)
1. Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37. Conti P; Stellin L; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560266 [TBL] [Abstract][Full Text] [Related]
2. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background. Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells. Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome. Soyfoo MS; Nicaise C Autoimmun Rev; 2021 Mar; 20(3):102756. PubMed ID: 33476812 [TBL] [Abstract][Full Text] [Related]
6. IL-33/ST2 axis in autoimmune disease. Shakerian L; Kolahdooz H; Garousi M; Keyvani V; Kamal Kheder R; Abdulsattar Faraj T; Yazdanpanah E; Esmaeili SA Cytokine; 2022 Oct; 158():156015. PubMed ID: 36041312 [TBL] [Abstract][Full Text] [Related]
7. Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiation. Kramer JM Cytokine; 2014 Jun; 67(2):92-101. PubMed ID: 24656928 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice. Hayashi Y; Haneji N; Hamano H Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145 [TBL] [Abstract][Full Text] [Related]
10. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis. de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164 [TBL] [Abstract][Full Text] [Related]
11. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model. Jin JO; Shinohara Y; Yu Q PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035 [TBL] [Abstract][Full Text] [Related]
12. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. Sakai A; Sugawara Y; Kuroishi T; Sasano T; Sugawara S J Immunol; 2008 Aug; 181(4):2898-906. PubMed ID: 18684981 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions. Zhou J; Jin JO; Patel ES; Yu Q Cytokine; 2015 Dec; 76(2):244-252. PubMed ID: 26255211 [TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases]. Tomás S; Coll J; Reth P; Corominas JM Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430 [TBL] [Abstract][Full Text] [Related]
15. Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter? Bartoloni E; Alunno A; Cafaro G; Valentini V; Bistoni O; Bonifacio AF; Gerli R Front Immunol; 2019; 10():817. PubMed ID: 31110500 [TBL] [Abstract][Full Text] [Related]
16. Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjögren's syndrome. Navarro-Mendoza EP; Aguirre-Valencia D; Posso-Osorio I; Correa-Forero SV; Torres-Cutiva DF; Loaiza D; Tobón GJ Autoimmun Rev; 2018 Jul; 17(7):709-714. PubMed ID: 29729452 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome. Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738 [TBL] [Abstract][Full Text] [Related]
18. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Peck AB; Nguyen CQ; Ambrus J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965 [TBL] [Abstract][Full Text] [Related]
19. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice. Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065 [TBL] [Abstract][Full Text] [Related]
20. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice. Zhou J; Jin JO; Du J; Yu Q Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]